Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of ASU 2016-13, net of tax effect
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Adoption of ASU 2016-13, net of tax effect
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Non-controlling Interest
Adoption of ASU 2016-13, net of tax effect
Beginning Balance (in shares) at Dec. 31, 2017     51,665            
Beginning Balance at Dec. 31, 2017 $ 642,781   $ 517 $ 770,983 $ (131,251)   $ (1,065) $ 3,597  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 41,798       41,577     221  
Unrealized gain (loss) on available-for-sale securities (1,177)           (1,171) (6)  
Unrealized gain (loss) on interest rate swaps 555           552 3  
Unrealized gain (loss) on interest rate swaps 555                
Issued shares of common stock (in shares)     8,611            
Issued shares of common stock 186,894   $ 86 186,808          
Equity-based compensation 10,772     10,715       57  
Issuance (repurchase) of vested equity-based compensation shares (in shares)     226            
Issuance (repurchase) of vested equity-based compensation shares (3,053)   $ 2 (3,055)          
Other (in shares)     8            
Other (146)     (67)       (79)  
Dividends and distributions (73,901)       (73,531)     (370)  
Ending Balance (in shares) at Dec. 31, 2018     60,510            
Ending Balance at Dec. 31, 2018 804,523   $ 605 965,384 (163,205)   (1,684) 3,423  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 81,920       81,564     356  
Unrealized gain (loss) on available-for-sale securities 11,249           11,200 49  
Unrealized gain (loss) on interest rate swaps (6,243)           (6,216) (27)  
Issued shares of common stock (in shares)     5,399            
Issued shares of common stock 138,401   $ 54 138,347          
Equity-based compensation 12,410     12,355       55  
Issuance (repurchase) of vested equity-based compensation shares (in shares)     425            
Issuance (repurchase) of vested equity-based compensation shares (9,169)   $ 4 (9,173)          
Other (in shares)     4            
Other (104)     (61)       (43)  
Tax basis difference on contributed asset (4,549)     (4,549)          
Dividends and distributions (88,526)       (88,145)     (381)  
Ending Balance (in shares) at Dec. 31, 2019     66,338            
Ending Balance at Dec. 31, 2019 $ 939,912 $ (14,105) $ 663 1,102,303 (169,786) $ (14,031) 3,300 3,432 $ (74)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Net income (loss) $ 82,759       82,416     343  
Unrealized gain (loss) on available-for-sale securities 12,437           12,380 57  
Unrealized gain (loss) on interest rate swaps (3,063)           (3,046) (17)  
Issued shares of common stock (in shares)     9,523            
Issued shares of common stock 298,471   $ 96 298,375          
Equity-based compensation 14,523     9,711       4,812  
Issuance (repurchase) of vested equity-based compensation shares (in shares)     537            
Issuance (repurchase) of vested equity-based compensation shares (17,287)   $ 6 (17,293)          
Other (in shares)     59            
Other 54     913       (859)  
Dividends and distributions (103,552)       (102,711)     (841)  
Ending Balance (in shares) at Dec. 31, 2020     76,457            
Ending Balance at Dec. 31, 2020 $ 1,210,149   $ 765 $ 1,394,009 $ (204,112)   $ 12,634 $ 6,853